Bupivacaine Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LQDA | C | Liquidia Technologies, Inc. | 1.20 | |
DRRX | C | DURECT Corporation | 1.52 | |
PCRX | C | Pacira Pharmaceuticals, Inc. | -0.18 | |
VRPX | D | Virpax Pharmaceuticals, Inc. | -0.83 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PJP | C | PowerShares Dynamic Pharmaceuticals | 3.85 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 3.0 | |
PILL | B | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 2.12 | |
SFLO | D | VictoryShares Small Cap Free Cash Flow ETF | 1.23 | |
CALF | D | Pacer US Small Cap Cash Cows 100 ETF | 0.95 |
Compare ETFs
- Bupivacaine
Bupivacaine, marketed under the brand name Marcaine among others, is a medication used to decrease feeling in a specific area. It is used by injecting it into the area, around a nerve that supplies the area, or into the spinal canal's epidural space. It is available mixed with a small amount of epinephrine to make it last longer. It typically begins working within 15 minutes and lasts for 2 to 8 hours.Possible side effects include sleepiness, muscle twitching, ringing in the ears, changes in vision, low blood pressure, and an irregular heart rate. Concerns exist that injecting it into a joint can cause problems with the cartilage. Concentrated bupivacaine is not recommended for epidural freezing. Epidural freezing may also increase the length of labor. It is a local anaesthetic of the amide group.Bupivacaine was discovered in 1957. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Bupivacaine is available as a generic medication and is not very expensive. The wholesale cost in the developing world of a vial is about US$2.10.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles